Most Active InvestorsFind investorsPricing
Start for free
Start for free
ATAI Life Sciences logo

ATAI Life Sciences

Europe, Bayern, Germany, Munich

Description

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

Investor Profile

ATAI Life Sciences has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 78% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Debt, Post Ipo Equity, Series B rounds (top funding stages).
  • Majority of deals are located in Canada, United Kingdom, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Post Ipo Debt (33%)
  • Post Ipo Equity (22%)
  • Series B (11%)
  • Series C (11%)
  • Corporate Round (11%)
  • Secondary Market (11%)

Country Focus

  • Canada (56%)
  • United Kingdom (33%)
  • Germany (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Life Science
  • Medical
  • Mental Health
  • Personal Health
  • Wellness
  • Analytics
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ATAI Life Sciences frequently co-invest with?

MC
McQuade Center for Strategic Research and Development
North America, New Jersey, United States, Princeton
Co-Investments: 1
Noetic Fund
Noetic Fund
North America, Ontario, Canada, Toronto
Co-Investments: 1
Able Partners
Able Partners
North America, New York, United States, New York
Co-Investments: 1
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
Skyviews Life Science
Skyviews Life Science
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 1
Soleus Capital
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Presight Capital
Presight Capital
North America, California, United States, West Hollywood
Co-Investments: 1
Block.one
Block.one
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
Camden Partners
Camden Partners
North America, Maryland, United States, Baltimore
Co-Investments: 1
Founders Fund
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does ATAI Life Sciences often collaborate with?

JM
Justin Mateen
North America, United States
Shared Deals: 1

What are some of recent deals done by ATAI Life Sciences?

Beckley Psytech

Beckley, Oxfordshire, United Kingdom

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

BiotechnologyHealth CareMedical
Secondary MarketJan 4, 2024
Amount Raised: $10,000,000
Beckley Psytech

Beckley, Oxfordshire, United Kingdom

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

BiotechnologyHealth CareMedical
Corporate RoundJan 4, 2024
Amount Raised: $40,000,000
IntelGenX

Saint Laurent, Quebec, Canada

IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityAug 31, 2023
Amount Raised: $2,220,471
IntelGenX

Saint Laurent, Quebec, Canada

IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.

BiotechnologyHealth CarePharmaceutical
Post Ipo DebtJan 9, 2023
Amount Raised: $3,000,000
IntelGenX

Saint Laurent, Quebec, Canada

IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.

BiotechnologyHealth CarePharmaceutical
Post Ipo DebtFeb 1, 2022
Amount Raised: $3,000,000
IntelGenX

Saint Laurent, Quebec, Canada

IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityMar 15, 2021
Amount Raised: $12,346,300
IntelGenX

Saint Laurent, Quebec, Canada

IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.

BiotechnologyHealth CarePharmaceutical
Post Ipo DebtMar 15, 2021
Amount Raised: $2,000,000
COMPASS Pathways

Altrincham, Cheshire, United Kingdom

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

BiotechnologyHealth CareLife ScienceMental HealthPersonal HealthWellness
Series BApr 27, 2020
Amount Raised: $80,000,000
Innoplexus

Eschborn, Hessen, Germany

Innoplexus™ - AI and Blockchain powered data analytics solutions help the life science industry gain real-time access to relevant insights

AnalyticsArtificial Intelligence (AI)BlockchainInformation TechnologyLife ScienceMachine LearningPharmaceutical
Series CApr 24, 2019
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator